use of low density oxidized lipoprotein immunotherapy, method for inducing regression of atherosclerotic plaques in an individual, use of at least one ldl antibody or at least one oxidized epitope of ldl, method for combating cardiovascular disease associated with atherosclerosis, use of at least an antibody molecule or at least one oxidized epitope of ldl and a statin, pharmaceutical formulation, part kit, methods for identifying an antibody that induces regression of atherosclerotic plaques in an individual and for identifying an agent that induces regression of atherosclerotic plaques in an individual, antibody, pharmaceutical composition, and antibody use

摘要

USE OF IMMUNOTHERAPY AGAINST LOW OXIDED DENSITY LIPOPROTEIN, METHOD FOR INDUCING REGULATION OF AEROSCLEROTIC PLATES IN AN INDIVIDUAL, USE OF AT LEAST ONE ANTIBODY OR AT LEAST ONE OXIDIZED EPOSTATE OF COMBINED COMBINATION, AN ANTIBODY MOLECULE OR AT LEAST AN OXIDIZED EPYPE OF LDL AND A STATINE, PHARMACEUTICAL FORMULATION, PARTS KIT, METHODS FOR IDENTIFYING AN ANTIBODY THAT INDUCES REGULATION OF ATEROSCLEROTIC PLATES IN AN INDIVIDUAL AND AGRICULTURAL PLATES AN INDIVIDUAL, ANTIBODY, PHARMACEUTICAL COMPOSITION, AND USE OF ANTIBODY. The use of immunotherapy against oxidized LDL to induce regression of pre-existing atherosclerotic lesions in an individual. Immunotherapy can be passive immunotherapy using antibodies that bind to epitopes present in oxidized LDL, or active immunotherapy using a vaccine composition to induce an immune response against epitopes present in oxidized LDL.